Literature DB >> 27098517

Innate defense mechanisms against HSV-1 infection in the target tissues, skin and brain.

Yael Tsalenchuck1, Israel Steiner2, Amos Panet3.   

Abstract

Herpes simplex virus type 1 (HSV-1) initiates productive infection in mucocutaneous tissues to cause cold sores and establishes latent infection in the trigeminal ganglia. Under certain circumstances, HSV-1 may cause encephalitis. Here, we compared host innate defenses against HSV-1 in the two clinically relevant tissues, skin and brain, using a unique ex vivo system of organ culture. Upon HSV-1 infection and spread, apoptosis induction was observed in the skin, but not in brain tissues. While the two tissues elicited interferon (IFN-β) response upon HSV1 infection, IFN induction was more robust in the skin compared to the brain. Moreover, antiviral response to exogenous IFNβ treatment was much stronger in the skin compared to brain tissues. This observation was not related to the availability of the IFN receptor on cells' surface. Taken together, our study demonstrates differential innate antiviral responses to HSV-1 infection that may be exploited in future development of selective and tissue-specific anti-viral treatments.

Entities:  

Keywords:  Herpes simplex virus type 1; Interferons; Peripheral sensory ganglia

Mesh:

Substances:

Year:  2016        PMID: 27098517     DOI: 10.1007/s13365-016-0440-9

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  50 in total

1.  Herpes simplex virus type 1 and Alzheimer's disease.

Authors:  Ruth F Itzhaki; Curtis B Dobson; Matthew A Wozniak
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

2.  Induction of apoptosis by herpes simplex virus type 1.

Authors:  A H Koyama; A Adachi
Journal:  J Gen Virol       Date:  1997-11       Impact factor: 3.891

3.  Restrictions that control herpes simplex virus type 1 infection in mouse brain ex vivo.

Authors:  Meytal Cohen; Efrat Braun; Yael Tsalenchuck; Amos Panet; Israel Steiner
Journal:  J Gen Virol       Date:  2011-06-22       Impact factor: 3.891

4.  The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.

Authors:  B He; M Gross; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

5.  Role of specific innate immune responses in herpes simplex virus infection of the central nervous system.

Authors:  Jennifer P Wang; Glennice N Bowen; Shenghua Zhou; Anna Cerny; An Zacharia; David M Knipe; Robert W Finberg; Evelyn A Kurt-Jones
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

Review 6.  Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature.

Authors:  I Valencia; D K Miles; J Melvin; D Khurana; S Kothare; H Hardison; A Legido
Journal:  Neuropediatrics       Date:  2004-12       Impact factor: 1.947

Review 7.  Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?

Authors:  Christopher D Conrady; Douglas A Drevets; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2009-10-09       Impact factor: 3.478

8.  Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1.

Authors:  Dustin Verpooten; Yijie Ma; Songwang Hou; Zhipeng Yan; Bin He
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

9.  Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells.

Authors:  W Cai; P A Schaffer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency.

Authors:  S K Thomas; G Gough; D S Latchman; R S Coffin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

View more
  4 in total

Review 1.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

2.  Different effects of the immunostimulatory drug Stimforte on infections of hepatitis C virus and herpes simplex virus type 1.

Authors:  D G Maldov; V L Andronova; S S Grigorian; E I Isaeva; P G Deryabin; D V Mishin; A A Balakina; A V Ilyichev; A A Terentyev; G A Galegov
Journal:  Dokl Biol Sci       Date:  2018-01-04

3.  Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.

Authors:  Or Alfi; Arkadi Yakirevitch; Ori Wald; Ori Wandel; Uzi Izhar; Esther Oiknine-Djian; Yuval Nevo; Sharona Elgavish; Elad Dagan; Ory Madgar; Gilad Feinmesser; Eli Pikarsky; Michal Bronstein; Olesya Vorontsov; Wayne Jonas; John Ives; Joan Walter; Zichria Zakay-Rones; Menachem Oberbaum; Amos Panet; Dana G Wolf
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

4.  Duck Plague Virus Promotes DEF Cell Apoptosis by Activating Caspases, Increasing Intracellular ROS Levels and Inducing Cell Cycle S-Phase Arrest.

Authors:  Chuankuo Zhao; Mingshu Wang; Anchun Cheng; Qiao Yang; Ying Wu; Renyong Jia; Dekang Zhu; Shun Chen; Mafeng Liu; XinXin Zhao; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang; Bin Tian; Mujeeb Ur Rehman; Leichang Pan; Xiaoyue Chen
Journal:  Viruses       Date:  2019-02-24       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.